Ignite Creation Date:
2024-05-06 @ 6:53 PM
Last Modification Date:
2024-10-26 @ 2:56 PM
Study NCT ID:
NCT05817435
Status:
COMPLETED
Last Update Posted:
2023-10-31
First Post:
2023-04-05
Brief Title:
A Phase 1 Bioequivalence Study of Efgartigimod PH20 SC Administered Via a Prefilled Syringe Versus a VialSyringe Presentation in Healthy Adults
Sponsor:
argenx
Organization:
argenx
Organization Data
Organization:
argenx
Class:
INDUSTRY
Study ID:
ARGX-113-2204
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
argenx
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None